Insider Ownership Activity for Dennis Langer

SEC Forms 3/4/5 positions, issuer links, and transaction evidence for this reporting owner.

Linked issuers

Largest position

MYRIAD GENETICS INC

Disclosed value

$2.17M

Transaction activity

Available

Reporting-owner positions (Forms 3/4/5): Forms 3/4/5 connect reporting owners to issuers, positions, and transactions disclosed to the SEC. They are filing-backed ownership signals, not a complete capitalization table.
Estimated position value
3/4/5
$2.17M
Estimated from parsed Forms 3/4/5 when filings include enough share and price data.
Linked issuers
3/4/5
3
Distinct issuers connected to this reporting owner in parsed SEC filings.
Largest linked position
3/4/5
MYRIAD GENETICS INC (MYGN)
$2.04M from parsed reporting-owner filings.
Latest parsed filing
SEC
06 Feb 2026
Most recent reporting-owner filing date in the parsed SEC record.
MYRIAD GENETICS INC (MYGN)
Filing-backed value: $2.04M · Role: Director
Quoin Pharmaceuticals, Ltd. (QNRX)
Filing-backed value: $128.6K · 12-month value change: +$128.6K · Role: Director
+1 more
Additional issuer positions are listed below.
How to read Forms 3/4/5 positions
Reported values are filing-backed estimates from parsed SEC Forms 3/4/5 when the filing includes enough share and price data.
Use this as reporting-owner context, not as a full capitalization table or a public-float ownership breakdown.
Reporting-owner location: Philadelpha, PA
Latest reporting-owner signature: /s/ Dennis Langer
Source filing history: Open source filing history

Follow Filing Activity

Follow Dennis Langer and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here